Astec LifeSciences Limited has scheduled its 32nd Annual General Meeting (AGM) for Friday, July 31, 2026, at 4:00 p.m. IST via Video Conferencing (VC) and Other Audio Visual Means (OAVM). The meeting will be held to transact business including the adoption of audited financial statements for the Financial Year 2025-26 and the ratification of the Cost Auditor's remuneration. The company has confirmed the completion of dispatch of the AGM notice and Annual Report to shareholders, with advertisements published in Business Standard and Mumbai Lakshadeep on July 9, 2026.

AGM Schedule and Key Dates

Shareholders should note the following key dates associated with the 32nd AGM:

The venue of the 32nd AGM shall be deemed to be the Registered Office of the Company at "Godrej One", 3rd Floor, Pirojshanagar, Eastern Express Highway, Vikhroli (East), Mumbai – 400 079, Maharashtra, India. E-voting facilities are being provided through the National Securities Depository Limited (NSDL) platform.

Agenda Items at the 32nd AGM

The following business items are proposed to be transacted at the 32nd AGM:

• Ordinary Business: Adoption of Audited Financial Statements (Standalone and Consolidated) for the Financial Year ended March 31, 2026, along with the Reports of the Board of Directors and Statutory Auditors.
• Ordinary Business: Re-appointment of Mr. Ashok V. Hiremath (DIN: 00349345), Non-Executive, Non-Independent Director, who retires by rotation and is eligible for re-appointment.
• Special Business: Ratification of remuneration of M/s. Tapan Gaitonde & Co., Cost Accountants, as Cost Auditor of the Company for the Financial Year ending March 31, 2027, at a remuneration of up to ₹1,50,000/- (Rupees One Lakh Fifty Thousand Only) per annum plus ₹15,000/- (Rupees Fifteen Thousand Only) towards XBRL compilation, plus applicable GST and reimbursement of out-of-pocket expenses.

IEPF and Unclaimed Dividend Notice

Shareholders are informed that the dividend amount for FY 2018-19 remaining unclaimed shall become due for transfer to the Investor Education and Protection Fund (IEPF) on Wednesday, August 26, 2026. Shareholders are requested to submit their claims preferably by Friday, August 7, 2026 to avoid transfer to IEPF. During FY 2025-26, 1,371 Equity Shares of Face Value of ₹10/- each, amounting to a nominal value of ₹13,710/-, were transferred to IEPF on account of unclaimed dividend for FY 2017-18.

Astec LifeSciences Limited secured shareholder approval for the appointment of four directors and related party transactions for the financial year 2026-27 through a postal ballot process that concluded on July 4, 2026. The resolutions, which included the appointment of Mr. Vishal Sharma and Mr. Burjis N. Godrej as Non-Executive, Non-Independent Directors liable to retire by rotation, were passed with the requisite majority. Additionally, Mr. Arijit Mukherjee was appointed as a Director and Executive Director while continuing as the Chief Operating Officer, and Mr. Mathew Eipe was appointed as an Independent Director.

Shareholders also approved ordinary resolutions for related party transactions with Godrej Agrovet Limited, the holding company, and Godrej Industries Limited, the ultimate holding company. These transactions, exceeding the materiality threshold under Regulation 23(4) of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, are authorized for the financial year 2026-27. The postal ballot notice was dispatched on June 2, 2026, to members registered as of the cut-off date of May 29, 2026, with remote e-voting facilitated through the National Securities Depository Limited (NSDL) platform from June 5, 2026, to July 4, 2026.

The scrutinizer's report, issued by Dr. Vikas Ramchandra Chomal of Vikas R. Chomal and Associates, validated the voting results. The report confirmed that all seven resolutions were passed, with the related party transactions resolutions receiving 52.86% votes in favour and 47.14% votes against. The detailed voting outcomes reflect the participation of promoters, public institutions, and public non-institutions through e-voting, while no physical postal ballots were received.

Voting Results Summary